| Medical and Health Sciences | Lifetime | 50 | NL 1 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 174 | NL 2 | 99.97 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 3 | NL 1 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 8 | NL 1 | 99.99 |
| Surgery | Lifetime | 249 | NL 7 | 99.79 |
| Pulmonary and Respiratory Medicine | Lifetime | 974 | NL 26 | 98.39 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 26 | NL 1 | 99.91 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 23 | NL 1 | 99.63 |
| Surgery | 2021-2025 | 294 | NL 10 | 98.07 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 635 | NL 22 | 92.42 |
| Epidemiology | 2021-2025 | 997 | NL 28 | 89.36 |
| Cardiac Imaging and Diagnostics | Lifetime | 3 | NL 1 | 99.99 |
| Cardiac Structural Anomalies and Repair | Lifetime | 2 | NL 1 | 99.97 |
| Cardiac Valve Diseases and Treatments | Lifetime | 6 | NL 1 | 99.97 |
| Cardiac pacing and defibrillation studies | Lifetime | 4 | NL 1 | 99.97 |
| Cardiovascular Function and Risk Factors | Lifetime | 8 | NL 1 | 99.98 |
| Advanced MRI Techniques and Applications | Lifetime | 18 | NL 1 | 99.88 |
| Advanced X-ray and CT Imaging | Lifetime | 12 | NL 1 | 99.82 |
| Cardiac Arrhythmias and Treatments | Lifetime | 9 | NL 1 | 99.94 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 23 | NL 1 | 99.87 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 54 | NL 3 | 99.74 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 84 | NL 5 | 99.70 |
| Coronary Interventions and Diagnostics | Lifetime | 41 | NL 2 | 99.83 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 97 | NL 10 | 99.67 |
| Acute Myocardial Infarction Research | Lifetime | 77 | NL 3 | 99.75 |
| Cardiomyopathy and Myosin Studies | Lifetime | 74 | NL 2 | 99.36 |
| Cardiovascular Disease and Adiposity | Lifetime | 105 | NL 2 | 99.37 |
| Medical Imaging Techniques and Applications | Lifetime | 367 | NL 20 | 98.68 |
| Cardiovascular Effects of Exercise | Lifetime | 124 | NL 3 | 99.07 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 270 | NL 10 | 98.56 |
| Aortic Disease and Treatment Approaches | Lifetime | 327 | NL 12 | 98.55 |
| Heart Failure Treatment and Management | Lifetime | 526 | NL 19 | 98.06 |
| Aortic aneurysm repair treatments | Lifetime | 436 | NL 24 | 97.60 |
| Radiation Dose and Imaging | Lifetime | 578 | NL 22 | 97.05 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 979 | NL 68 | 97.70 |
| Hemodynamic Monitoring and Therapy | Lifetime | 762 | NL 34 | 96.22 |
| Pericarditis and Cardiac Tamponade | Lifetime | 231 | NL 2 | 94.25 |
| Ultrasound in Clinical Applications | Lifetime | 651 | NL 23 | 93.59 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 640 | NL 21 | 79.80 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 6 | NL 1 | 99.88 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 9 | NL 2 | 99.80 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 14 | NL 1 | 99.90 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 27 | NL 2 | 99.82 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 51 | NL 2 | 99.32 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 39 | NL 1 | 97.40 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 186 | NL 12 | 98.52 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 156 | NL 9 | 98.53 |
| Coronary Interventions and Diagnostics | 2021-2025 | 147 | NL 5 | 98.11 |
| Acute Myocardial Infarction Research | 2021-2025 | 167 | NL 6 | 97.55 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 189 | NL 8 | 95.65 |
| Advanced X-ray and CT Imaging | 2021-2025 | 259 | NL 14 | 94.95 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 392 | NL 17 | 95.69 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 335 | NL 14 | 94.13 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 460 | NL 29 | 90.39 |
| Congenital Heart Disease Studies | 2021-2025 | 860 | NL 38 | 88.83 |
| Radiation Dose and Imaging | 2021-2025 | 654 | NL 23 | 87.53 |
| Ultrasound in Clinical Applications | 2021-2025 | 806 | NL 23 | 76.29 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 581 | NL 3 | 50.36 |
